Mycophenolic Acid Activation of p53 Requires Ribosomal Proteins L5 and L11*

Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G1 cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.

• Publication year

  2008

• Venue

  Journal of Biological Chemistry

• Publication date

  2008-05-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M801387200PMID 18305114PMCID PMC2430998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• S6-Haploinsufficiency Activates the p53 Tumor Suppressor

  2007cited by this paper
• Inhibition of c‐Myc activity by ribosomal protein L11

  2007cited by this paper
• 5-Fluorouracil Activation of p53 Involves an MDM2-Ribosomal Protein Interaction*

  2007cited by this paper
• Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function

  2007cited by this paper
• Regulation of the MDM2-p53 Pathway by Ribosomal Protein L11 Involves a Post-ubiquitination Mechanism*

  2006cited by this paper
• IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells

  2006cited by this paper
• Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.

  2005cited by this paper
• Mechanisms of action of mycophenolate mofetil

  2005cited by this paper
• Mechanisms of action of mycophenolate mofetil

  2005cited by this paper
• A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin

  2005cited by this paper
• Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease.

  2005cited by this paper
• Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway

  2005cited by this paper
• Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis.

  2005cited by this paper
• NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS

  2004cited by this paper
• Inhibition of HDM2 and Activation of p53 by Ribosomal Protein L23

  2004cited by this paper
• Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition

  2004cited by this paper
• Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation

  2004cited by this paper
• Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines

  2004cited by this paper
• Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5*

  2004cited by this paper
• Potential Role of Mycophenolate Mofetil in the Management of Neuroblastoma Patients

  2004cited by this paper
• Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway

  2003cited by this paper
• Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion.

  2003cited by this paper
• Regulation of HDM2 activity by the ribosomal protein L11.

  2003cited by this paper
• Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides1

  2003cited by this paper
• Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition

  2001cited by this paper
• Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients

  2001cited by this paper
• Differentiation induction in non-lymphocytic leukemia cells upon treatment with mycophenolate mofetil.

  2000cited by this paper
• In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes.

  2000cited by this paper
• Stress Signals Utilize Multiple Pathways To Stabilize p53

  2000cited by this paper
• The economics of ribosome biosynthesis in yeast.

  1999cited by this paper
• Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes.

  1998cited by this paper
• Differentiation and Reduction of Intracellular GTP Levels in Hl-60 and U937 Cells Upon Treatment with IMP Dehydrogenase Inhibitors

  1998cited by this paper
• Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis.

  1998cited by this paper
• Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.

  1997cited by this paper
• A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.

  1996cited by this paper
• p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.

  1994cited by this paper
• Characterization of human type I and type II IMP dehydrogenases.

  1993cited by this paper
• Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells.

  1992cited by this paper
• Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias.

  1991cited by this paper
• Two distinct cDNAs for human IMP dehydrogenase.

  1990cited by this paper
• Depletion of guanine nucleotides with mycophenolic acid suppresses IgE receptor-mediated degranulation in rat basophilic leukemia cells.

  1989cited by this paper
• Guanine for DNA synthesis. A compulsory route through ribonucleotide reductase.

  1988cited by this paper
• Compartmentation of guanine nucleotide precursors for DNA synthesis.

  1986cited by this paper
• The role of de novo purine synthesis in lymphocyte transformation.

  1977cited by this paper
• IMP dehydrogenase, an enzyme linked with proliferation and malignancy

  1975cited by this paper

• The influence of IMPDH activity on ciliogenesis and adipogenesis of 3T3-L1 cells while undergoing differentiation.

  2025cites this paper
• Establishment of an imaging-based screening pipeline for the identification of human ribosome biogenesis inhibitors

  2025cites this paper
• Sasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p

  2025cites this paper
• IMPDH inhibition induces DNA replication stress and ATR sensitivity in Merkel cell carcinoma

  2025cites this paper
• The Central Role of Ribosomal Proteins in p53 Regulation

  2025cites this paper
• IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope

  2025cites this paper
• IMPDH Inhibition Decreases TERT Expression and Synergizes the Cytotoxic Effect of Chemotherapeutic Agents in Glioblastoma Cells

  2024cites this paper
• UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis

  2023cites this paper
• Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group

  2022cites this paper
• Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward

  2022cites this paper
• Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress

  2022influential citation
• IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia

  2022cites this paper
• Ribosomopathies and cancer: pharmacological implications

  2022cites this paper
• The important role of MDM2, RPL5, and TP53 in mycophenolic acid-induced cleft lip and palate

  2021cites this paper
• Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses.

  2021cites this paper
• The important role of RPS14, RPL5 and MDM2 in TP53-associated ribosome stress in mycophenolic acid-induced microtia.

  2021cites this paper
• Coupling Between Cell Cycle Progression and the Nuclear RNA Polymerases System

  2021cites this paper
• PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53

  2021cites this paper
• Distribution and vulnerability of transcriptional outputs across the genome in Myc-amplified medulloblastoma cells

  2021cites this paper
• Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent.

  2020cites this paper
• Che-1/AATF binds to RNA polymerase I machinery and sustains ribosomal RNA gene transcription

  2020cites this paper
• Phytochemicals in Cancer with Special Emphasis on Ovarian Cancer

  2020influential citation
• Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage

  2020influential citation
• RBM10, a New Regulator of p53

  2020cites this paper
• Monoclonal antibody AC10364 inhibits cell proliferation in 5-fluorouracil resistant hepatocellular carcinoma via apoptotic pathways

  2019cites this paper
• p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and Its Combination Effect with RITA or Doxorubicin

  2019cites this paper
• OTT_A_206517 5053..5067

  2019cites this paper
• Determination and validation of mycophenolic acid by a UPLC-MS/MS method: Applications to pharmacokinetics and tongue tissue distribution studies in rats.

  2019cites this paper
• Inhibition of tRNA Gene Transcription by the Immunosuppressant Mycophenolic Acid

  2019cites this paper
• Comparative proteomics analysis reveals the difference during antler regeneration stage between red deer and sika deer

  2019cites this paper
• Evidence for nucleolar dysfunction in Alzheimer’s disease

  2019cites this paper
• Involvement of RPL11 in the enhancement of P53 stability by a podophyllum derivative, a topoisomerase II inhibitor

  2018cites this paper
• Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why

  2018cites this paper
• The roles of moonlight ribosomal proteins in the development of human cancers

  2018cites this paper
• SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer

  2018cites this paper
• Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.

  2017cites this paper
• SPIN1 promotes tumorigenesis by blocking the uL18-MDM2-p53 pathway

  2017cites this paper
• Study of the Ribosomal Stress Pathway in Pluripotency, Cancer and Disease

  2016cites this paper
• Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate

  2016cites this paper
• Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop

  2016cites this paper
• mTOR: An attractive therapeutic target for osteosarcoma?

  2016cites this paper
• Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation

  2016cites this paper
• TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene

  2016cites this paper
• Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts

  2016cites this paper
• Effective Antitumor Candidates Based upon Ferrocenylseleno-Dopamine Derivatives: Growth Inhibition by Induction Cell Apoptosis and Antivascular Effects

  2016cites this paper
• rRNA SYNTHESIS-INHIBITING DRUGS IN ANTINEOPLASTIC THERAPY : p 53 STABILIZATION LEVEL IS DIRECTLY RELATED TO THE CELL RIBOSOME BIOGENESIS RATE

  2016cites this paper
• Novel functions of USP36 : regulation of histone 2B and the P53-MDM2 pathway through deubiquitination

  2015cites this paper
• Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer

  2015cites this paper
• A liaison between mTOR signaling, ribosome biogenesis and cancer.

  2015cites this paper
• Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications

  2015cites this paper
• Ribosomal proteins: functions beyond the ribosome.

  2015cites this paper
• Inauhzin(c) Inactivates c-Myc Independently of p53

  2015cites this paper
• Nucleolar stress with and without p53

  2014influential citation
• Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition

  2014cites this paper
• The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress

  2014influential citation
• Nucleolar Stress Induces Ubiquitination-independent Proteasomal Degradation of PICT1 Protein*

  2014cites this paper
• The ribosomal protein S26 regulates p53 activity in response to DNA damage

  2014cites this paper
• Growth inhibitory effects of large subunit ribosomal proteins in melanoma

  2014cites this paper
• Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.

  2014cites this paper
• mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels

  2014cites this paper
• Therapeutic utility of targeting protein synthetic machinery in melanoma

  2014influential citation
• Nucleolar Signaling Determines Cell Fate: The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis

  2014cites this paper
• Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acid.

  2013cites this paper
• RYBP stabilizes p 53 by modulating MDM 2

  2013cites this paper
• Die Verteilung transkribierender RNA-Polymerase I auf ribosomaler DNA

  2013cites this paper
• The Interactome of Protein Kinase CK2

  2013cites this paper
• The regulation of RNA polymerase III-mediated transcription by p53, AP-1 and JNKs

  2013cites this paper
• The Nucleolus as a Stress Response Organelle

  2013cites this paper
• Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress

  2013cites this paper
• Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

  2013cites this paper
• Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop

  2013cites this paper
• Ribosomal Proteins L5 and L11 Cooperatively Inactivate c-Myc via RNA-induced Silencing Complex

  2013cites this paper
• Balanced Production of Ribosome Components Is Required for Proper G1/S Transition in Saccharomyces cerevisiae *

  2013cites this paper
• PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression

  2013cites this paper
• Negative Regulation of HDM 2 by Ribosomal Protein L 26 Attenuates p 53 Degradation

  2013cites this paper
• Physical and Functional Interaction between Ribosomal Protein L11 and the Tumor Suppressor ARF*

  2012cites this paper
• Characterization of an HIV-Targeted Transcriptional Gene-Silencing RNA in Primary Cells

  2012influential citation
• Scission of the p53-MDM2 Loop by Ribosomal Proteins.

  2012cites this paper
• Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential.

  2012cites this paper
• Depletion of Nucleostemin in Response to GTP Ligase-independent Proteasomal Turnover Ubiquitin-and MDM 2 E 3 Protein Synthesis and Degradation :

  2012cites this paper
• p53 -Dependent and -Independent Nucleolar Stress Responses

  2012cites this paper
• The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives.

  2012cites this paper
• Ubiquitin- and MDM2 E3 Ligase-independent Proteasomal Turnover of Nucleostemin in Response to GTP Depletion*

  2012cites this paper
• Proteomic investigation of the molecular targets of mycophenolic acid in human cells

  2012cites this paper
• A new PICTure of nucleolar stress

  2012cites this paper
• Antibodies against ribosomal protein S29 (RPS29) fused with glutathione's transferase specially react with native RPS29 in mouse and human cells

  2011cites this paper
• The Role of the Nucleolus in the Stress Response

  2011cites this paper
• Differentiation Function Depending on the Stage of Mycophenolic Acid Differentially Impacts B Cell

  2011cites this paper
• Autoregulatory Suppression of c-Myc by miR-185-3p*

  2011cites this paper
• MODULATION OF P53 SIGNALING IN an APT121 INDUCED PROSTATE CANCER MODEL

  2011influential citation
• Hydrophilic Residues Are Crucial for Ribosomal Protein L11 (RPL11) Interaction with Zinc Finger Domain of MDM2 and p53 Protein Activation*

  2011cites this paper
• Ribosomal Protein L11 Recruits miR-24/miRISC To Repress c-Myc Expression in Response to Ribosomal Stress

  2011cites this paper
• Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11

  2011cites this paper
• GTP depletion synergizes the anti-proliferative activity of chemotherapeutic agents in a cell type-dependent manner.

  2011cites this paper
• Interplay between Ribosomal Protein S27a and MDM2 Protein in p53 Activation in Response to Ribosomal Stress*

  2011cites this paper
• Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation

  2011cites this paper
• The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine.

  2011influential citation
• DifferentiationCell Function Depending on the Stage of Mycophenolic Acid Differentially Impacts B

  2011cites this paper
• Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment

  2011cites this paper
• Nucleostemin

  2010cites this paper